Figure Technology Solutions Inc. Class A Common Stock vs Liquidia Corporation Common Stock — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $24.81 (market cap $6.11B), while Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B). The key difference: Figure Technology Solutions Inc. Class A Common Stock is far larger — about 2.5× Liquidia Corporation Common Stock's market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 6 Days and Liquidia Corporation Common Stock for 0 Days on average.
| FIGR | LQDA | |
|---|---|---|
Market Cap | $6.11B | $2.40B |
Volume | 5,025,604 | 2,857,547 |
Sector | Financials | Health |
52-Week High | $73.91 | $91.03 |
52-Week Low | $24.91 | $22.02 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $6.15B | $2.30B |
Signals from Pluang's Aura AI — not financial advice
FIGR trades at $27.25, down 4.25% over 24 hours, with a bearish technical signal from moving averages. The company reported strong fundamentals: Q2 2026 EPS beat expectations at $0.37, revenue grew to $509.30M in 2025, and net income margin improved to 33.83% in 2026. Recent news highlights the Kiavi acquisition and partnership with Sierra to enhance AI-driven lending capabilities, supporting growth in loan volumes.
Wall Street maintains a bullish outlook with a consensus price target of $50.00, implying significant upside. However, risks include recent earnings misses in Q4 2025 and Q1 2026, negative operating cash flow projected for 2026, and competitive pressures in the lending infrastructure space. The stock's high P/E of 28.52 warrants caution amid growth execution uncertainties.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.
Read more on FIGR →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →